7/8 Huge thanks to co-lead Nich Marston, co-authors: Giorgio Melloni, S. Jurgens, F. Kamanu, Yi-Pin Lai, @joelramo.bsky.social, I.Raz & S.Wiviott, senior authors Patrick Ellinor, Marc Sabatine, and Christian Ruff. Incredible effort #UKEHamburg , #TIMIStudyGroup @mgbresearch.bsky.social
June 8, 2026 at 7:20 PM
7/8 Huge thanks to co-lead Nich Marston, co-authors: Giorgio Melloni, S. Jurgens, F. Kamanu, Yi-Pin Lai, @joelramo.bsky.social, I.Raz & S.Wiviott, senior authors Patrick Ellinor, Marc Sabatine, and Christian Ruff. Incredible effort #UKEHamburg , #TIMIStudyGroup @mgbresearch.bsky.social
2) Our returning expert faculty is Sid Patel MD @SidPatelMD #Cardiologist @HarvardMed @TIMIStudyGroup. Sid helped lead the #AZALEA trial and presented the first secondary analysis from it at #ESC2024, from which you can still earn CE/#CME at cardiometabolic-ce.com/antithrombot...
December 12, 2024 at 8:23 PM
2) Our returning expert faculty is Sid Patel MD @SidPatelMD #Cardiologist @HarvardMed @TIMIStudyGroup. Sid helped lead the #AZALEA trial and presented the first secondary analysis from it at #ESC2024, from which you can still earn CE/#CME at cardiometabolic-ce.com/antithrombot...
10) So @SidPatelMD was in the room here at #AHA24 for @cardiomet_CE as @TIMIStudyGroup #fellow Samer Al Said @sameralsaid presented a second preplanned analysis from #AZALEA TIMI_71, looking at concomitant use of #OAPs with either #abelacimab or #rivaroxaban.
December 12, 2024 at 8:23 PM
10) So @SidPatelMD was in the room here at #AHA24 for @cardiomet_CE as @TIMIStudyGroup #fellow Samer Al Said @sameralsaid presented a second preplanned analysis from #AZALEA TIMI_71, looking at concomitant use of #OAPs with either #abelacimab or #rivaroxaban.